Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses
► Multiplex PCR screening of clinical specimens from acute respiratory tract infections. ► Viruses found were influenza, entero/rhino, corona, adeno, boca, PI, RSV, and hMPV. ► After 3 or less passages in MDCK 33016 PF cells, only influenza virus was found. ► Co-infections together with influenza vi...
Saved in:
Published in | Vaccine Vol. 30; no. 3; pp. 517 - 522 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
11.01.2012
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ► Multiplex PCR screening of clinical specimens from acute respiratory tract infections. ► Viruses found were influenza, entero/rhino, corona, adeno, boca, PI, RSV, and hMPV. ► After 3 or less passages in MDCK 33016 PF cells, only influenza virus was found. ► Co-infections together with influenza virus were lost within 2–3 MDCK passages. ► MDCK cells represent a barrier for co-infecting viruses in influenza vaccine strains.
This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ∼104), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses. |
---|---|
AbstractList | ► Multiplex PCR screening of clinical specimens from acute respiratory tract infections. ► Viruses found were influenza, entero/rhino, corona, adeno, boca, PI, RSV, and hMPV. ► After 3 or less passages in MDCK 33016 PF cells, only influenza virus was found. ► Co-infections together with influenza virus were lost within 2–3 MDCK passages. ► MDCK cells represent a barrier for co-infecting viruses in influenza vaccine strains.
This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ∼10
4
), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses. This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ∼10(4)), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses.This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ∼10(4)), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses. Highlights► Multiplex PCR screening of clinical specimens from acute respiratory tract infections. ► Viruses found were influenza, entero/rhino, corona, adeno, boca, PI, RSV, and hMPV. ► After 3 or less passages in MDCK 33016 PF cells, only influenza virus was found. ► Co-infections together with influenza virus were lost within 2–3 MDCK passages. ► MDCK cells represent a barrier for co-infecting viruses in influenza vaccine strains. ► Multiplex PCR screening of clinical specimens from acute respiratory tract infections. ► Viruses found were influenza, entero/rhino, corona, adeno, boca, PI, RSV, and hMPV. ► After 3 or less passages in MDCK 33016 PF cells, only influenza virus was found. ► Co-infections together with influenza virus were lost within 2–3 MDCK passages. ► MDCK cells represent a barrier for co-infecting viruses in influenza vaccine strains. This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ∼104), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses. This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ∼10(4)), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses. Highlights * Multiplex PCR screening of clinical specimens from acute respiratory tract infections. * Viruses found were influenza, entero/rhino, corona, adeno, boca, PI, RSV, and hMPV. * After 3 or less passages in MDCK 33016 PF cells, only influenza virus was found. * Co-infections together with influenza virus were lost within 2-3 MDCK passages. * MDCK cells represent a barrier for co-infecting viruses in influenza vaccine strains. This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ∼10⁴), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses. This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after passaging of virus-positive samples in MDCK 33016PF cells. Using the ResPlexII v2.0 (Qiagen) multiplex PCR, 393 positive results were obtained in 468 clinical samples collected during an influenza season in Germany. The overall distribution of positive results was influenza A 42.0%, influenza B 38.7%, adenovirus 1.5%, bocavirus 0.5%, coronavirus 3.3%, enterovirus 5.6%, metapneumovirus 1.0%, parainfluenza virus 0.8%, rhinovirus 4.1%, and respiratory syncytial virus (RSV) 2.5%. Double infections of influenza virus together with another virus were found for adenovirus B and E, bocavirus, coronavirus, enterovirus and for rhinovirus. These other viruses were rapidly lost upon passages in MDCK 33016PF cells and under conditions as applied to influenza virus passaging. Clinical samples, in which no influenza virus but other viruses were found, were also subject to passages in MDCK 33016PF cells. Using lower inoculum dilutions than those normally applied for preparations containing influenza virus (total dilution of the original sample of ~104), the positive results for the different viruses turned negative already after 2 or 3 passages in MDCK 33016PF cells. These results demonstrate that, under practical conditions as applied to grow influenza viruses, contaminating viruses can be effectively removed by passages in MDCK cells. In combination with their superior isolation efficiency, MDCK cells appear highly suitable to be used as an alternative to embryonated eggs to isolate and propagate influenza vaccine candidate viruses. |
Author | Enders, Martin Gregersen, Jens-Peter Mohr, Hannah Garten, Wolfgang Roth, Bernhard |
AuthorAffiliation | a Novartis Vaccines and Diagnostics GmbH, Emil von Behring Str. 76, 35041 Marburg, Germany b Phillips University Marburg, Institute for Virology, Hans-Meerwein-Straße 2, 35043 Marburg, Germany c Laboratory Prof. G. Enders & Partners, Rosenbergstraße 85, 70193 Stuttgart, Germany |
AuthorAffiliation_xml | – name: b Phillips University Marburg, Institute for Virology, Hans-Meerwein-Straße 2, 35043 Marburg, Germany – name: c Laboratory Prof. G. Enders & Partners, Rosenbergstraße 85, 70193 Stuttgart, Germany – name: a Novartis Vaccines and Diagnostics GmbH, Emil von Behring Str. 76, 35041 Marburg, Germany |
Author_xml | – sequence: 1 givenname: Bernhard surname: Roth fullname: Roth, Bernhard email: bernhard.roth@novartis.com organization: Novartis Vaccines and Diagnostics GmbH, Emil von Behring Str. 76, 35041 Marburg, Germany – sequence: 2 givenname: Hannah surname: Mohr fullname: Mohr, Hannah organization: Novartis Vaccines and Diagnostics GmbH, Emil von Behring Str. 76, 35041 Marburg, Germany – sequence: 3 givenname: Martin surname: Enders fullname: Enders, Martin organization: Laboratory Prof. G. Enders & Partners, Rosenbergstraße 85, 70193 Stuttgart, Germany – sequence: 4 givenname: Wolfgang surname: Garten fullname: Garten, Wolfgang organization: Phillips University Marburg, Institute for Virology, Hans-Meerwein-Straße 2, 35043 Marburg, Germany – sequence: 5 givenname: Jens-Peter surname: Gregersen fullname: Gregersen, Jens-Peter organization: Novartis Vaccines and Diagnostics GmbH, Emil von Behring Str. 76, 35041 Marburg, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22119922$$D View this record in MEDLINE/PubMed |
BookMark | eNqNk11v0zAYhS00xLrCTwAicQE3Lf5IYluIIVQYTAyBNCZxZznOm-IutYudVCq_Hod2AyrBJlmKlDzn2O_J8RE6cN4BQg8JnhJMyueL6VobYx1MKSZkmhYu2R00IoKzCS2IOEAjTMt8khP89RAdxbjAGBeMyHvokFJCpKR0hOan0be6s95lvsmsa9oe3A-drW3oI8T0Jvv4ZvYhYyxt-vkkM9C2MdOuzkwLOmhnYBAa7zq9tC45uXkWIK5s0J0Pmyuj--huo9sID3bPMbo4eftl9n5y9und6ez12cTwQnQTKKXgHCRwrVllKOQci4JQzkDTvDGigKJqoDSMVlSYvG5YVbGEiVrLugA2Rsdb31VfLaE24LqgW7UKdqnDRnlt1d9fnP2m5n6tOGFYEJYMnu4Mgv_eQ-zU0sZhau3A91FJIlKKnJFbkJRLLkSZyGf_JUnJRUGlzGlCn-yhC98HlyJTJJecSVoynKhHf055Pd7Vf01AsQVM8DEGaK4RgtXQH7VQu_6ooT8qrdSfpHuxpzO2-1WPFJZtb1Q_3qob7ZWeBxvVxXkCCoxJnro4nOvVloDUgbWFoKKxkEpU2wCmU7W3N-5xvOdgWuus0e0lbCD-TktFqrA6H-7AcAVI8hRFSnCMXv7b4BYH-AkuTxdN |
CitedBy_id | crossref_primary_10_1080_14760584_2019_1639503 crossref_primary_10_1080_21645515_2015_1016666 crossref_primary_10_1016_j_ajic_2020_05_026 crossref_primary_10_1016_j_vaccine_2014_04_072 crossref_primary_10_1016_j_vaccine_2019_08_064 crossref_primary_10_1586_14760584_2015_1039520 crossref_primary_10_1016_j_vaccine_2016_05_031 crossref_primary_10_1038_s41541_018_0079_z crossref_primary_10_1038_s41541_021_00415_3 crossref_primary_10_33321_cdi_2021_45_43 crossref_primary_10_1111_1348_0421_12985 crossref_primary_10_1111_irv_12694 crossref_primary_10_1099_vir_0_044388_0 crossref_primary_10_35772_ghm_2023_01070 |
Cites_doi | 10.1128/JVI.64.4.1808-1811.1990 10.1016/j.vaccine.2009.02.064 10.1038/nbt1261 10.1007/s10096-009-0780-y 10.1016/j.vaccine.2008.03.076 10.1586/erv.09.128 10.1128/JCM.01621-06 10.1016/S0264-410X(03)00071-9 10.3201/eid1410.080545 10.1038/303706a0 10.1002/jmv.1890440403 10.1002/jmv.20243 10.1086/508219 10.1128/JCM.38.3.1170-1174.2000 10.1111/j.1651-2227.2008.01023.x 10.1002/rmv.1980030206 10.1093/infdis/160.2.191 10.1128/JCM.41.1.149-154.2003 10.1016/S1386-6532(03)00122-7 10.1002/jmv.10225 10.1086/521308 10.1128/JCM.00027-07 10.1128/JCM.10.1.32-36.1979 10.1086/650171 10.1016/j.vaccine.2008.03.075 |
ContentType | Journal Article |
Copyright | 2011 Elsevier Ltd Elsevier Ltd Copyright © 2011 Elsevier Ltd. All rights reserved. Copyright Elsevier Limited Jan 11, 2012 Copyright © 2011 Elsevier Ltd. 2011 Elsevier Ltd |
Copyright_xml | – notice: 2011 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright © 2011 Elsevier Ltd. All rights reserved. – notice: Copyright Elsevier Limited Jan 11, 2012 – notice: Copyright © 2011 Elsevier Ltd. 2011 Elsevier Ltd |
DBID | 6I. AAFTH FBQ AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7RV 7T2 7T5 7U9 7X7 7XB 88C 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9- K9. KB0 LK8 M0R M0S M0T M1P M2O M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7S9 L.6 7X8 7ST SOI 5PM |
DOI | 10.1016/j.vaccine.2011.11.063 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access AGRIS CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Nursing & Allied Health Database Health and Safety Science Abstracts (Full archive) Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Consumer Health Database Health & Medical Collection (Alumni) Healthcare Administration Database Medical Database Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic AGRICOLA AGRICOLA - Academic MEDLINE - Academic Environment Abstracts Environment Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library Health & Safety Science Abstracts ProQuest Public Health ProQuest Central Basic ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library Immunology Abstracts ProQuest Central (Alumni) AGRICOLA AGRICOLA - Academic MEDLINE - Academic Environment Abstracts |
DatabaseTitleList | MEDLINE - Academic MEDLINE Research Library Prep AGRICOLA AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database – sequence: 4 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Veterinary Medicine Biology Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-2518 |
EndPage | 522 |
ExternalDocumentID | PMC7130813 3217319211 22119922 10_1016_j_vaccine_2011_11_063 US201500142642 S0264410X11018597 1_s2_0_S0264410X11018597 |
Genre | Journal Article |
GeographicLocations | Germany |
GeographicLocations_xml | – name: Germany |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABKYH ABMAC ABMZM ABRWV ABUWG ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEUYN AEVXI AEXOQ AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGGSO AGUBO AGYEJ AHMBA AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX AQUVI AXJTR AZQEC BBNVY BENPR BHPHI BKEYQ BKNYI BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU CJTIS CNWQP CS3 DWQXO EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN FYUFA G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK HZ~ IHE J1W K9- KOM L7B LK8 LUGTX LW9 M0R M0T M1P M29 M2O M41 M7P MO0 N9A NAPCQ O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO Q38 ROL RPZ SAB SCC SDF SDG SDP SES SNL SPCBC SSH SSI SSZ T5K UKHRP UV1 WH7 WOW Z5R ~G- .GJ 29Q 3V. AACTN AAQXK ADVLN AFCTW AFJKZ AFKWA AGHFR AHHHB AJOXV ALIPV AMFUW ASPBG AVWKF AZFZN FEDTE FGOYB G-2 HEJ HLV HMG HMK HMO HVGLF HX~ R2- RIG SAE SEW SIN SVS WUQ XPP ZGI ZXP 6I. AAFTH AAIAV ABLVK ABYKQ AESVU AJBFU EFLBG LCYCR QYZTP ABPIF ABPTK FBQ AAYXX ACMHX ADSLC AGQPQ AGRNS AGWPP AIGII APXCP CITATION CGR CUY CVF ECM EIF NPM 7QL 7T2 7T5 7U9 7XB 8FK C1K H94 K9. M7N MBDVC PKEHL PQEST PQUKI PRINS Q9U 7S9 L.6 7X8 7ST SOI 5PM |
ID | FETCH-LOGICAL-c758t-e69877e9e7aa3bc2e470851273ea24fc85e5bfe6c32b28c4df3bb32e48da9d5e3 |
IEDL.DBID | .~1 |
ISSN | 0264-410X 1873-2518 |
IngestDate | Thu Aug 21 18:14:29 EDT 2025 Tue Aug 05 10:12:09 EDT 2025 Thu Jul 10 23:30:50 EDT 2025 Mon Jul 21 10:15:15 EDT 2025 Wed Aug 13 11:32:37 EDT 2025 Thu Apr 03 07:07:06 EDT 2025 Thu Apr 24 23:09:14 EDT 2025 Tue Jul 01 03:37:56 EDT 2025 Wed Dec 27 19:21:10 EST 2023 Fri Feb 23 02:31:56 EST 2024 Sun Feb 23 10:19:15 EST 2025 Tue Aug 26 17:46:44 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | MDCK cells Influenza vaccine Virus isolation Adventitious viruses |
Language | English |
License | http://creativecommons.org/licenses/by-nc-nd/3.0 https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2011 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c758t-e69877e9e7aa3bc2e470851273ea24fc85e5bfe6c32b28c4df3bb32e48da9d5e3 |
Notes | http://dx.doi.org/10.1016/j.vaccine.2011.11.063 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0264410X11018597 |
PMID | 22119922 |
PQID | 1497392630 |
PQPubID | 105530 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7130813 proquest_miscellaneous_918053731 proquest_miscellaneous_912797886 proquest_miscellaneous_1678529942 proquest_journals_1497392630 pubmed_primary_22119922 crossref_primary_10_1016_j_vaccine_2011_11_063 crossref_citationtrail_10_1016_j_vaccine_2011_11_063 fao_agris_US201500142642 elsevier_sciencedirect_doi_10_1016_j_vaccine_2011_11_063 elsevier_clinicalkeyesjournals_1_s2_0_S0264410X11018597 elsevier_clinicalkey_doi_10_1016_j_vaccine_2011_11_063 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-01-11 |
PublicationDateYYYYMMDD | 2012-01-11 |
PublicationDate_xml | – month: 01 year: 2012 text: 2012-01-11 day: 11 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands – name: Kidlington |
PublicationTitle | Vaccine |
PublicationTitleAlternate | Vaccine |
PublicationYear | 2012 |
Publisher | Elsevier Ltd Elsevier Limited |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
References | Stempel, Martin, Kuypers, Englund, Zerr (bib0120) 2009; 98 Matthews (bib0100) 2006; 36 Katz, Webster (bib0020) 1989; 160 Dare, Sanghavi, Bullotta, Keightley, George, Wadowsky (bib0090) 2007; 45 Minor (bib0110) 2010; 50 Genzel, Reichl (bib0030) 2009; 8 Ulmer, Valley, Rappuoli (bib0105) 2006; 24 Manning, Russel, Eastick, Leadbetter, Hallam, Tempelton (bib0115) 2006; 194 Eggers, Roth, Schweiger, Schmid, Gregersen, Enders (bib0135) 2011 Gregersen (bib0040) 2008; 26 Mori, Clewley (bib0070) 1994; 44 Dare, Fry, Chittaganpitch, Sawanpanyalert, Olsen, Erdman (bib0080) 2007; 196 Oxford, Corcoran, Knott, Bates, Bartolomei, Major (bib0015) 1987; 65 Gerdil (bib0095) 2003; 21 Robertson (bib0010) 1993; 3 Ward, Dempsey, Ring, Kempson, Zhang, Gor (bib0050) 2004; 29 De Vos, Vankeerberghen, Vaeyens, Van Vaerenbergh, Boel, De Beenhouwer (bib0125) 2009; 28 Frank, Couch, Griffis, Baxter (bib0140) 1979; 10 Katz, Wang, Webster (bib0025) 1990; 64 Venter, Collinson, Schoub (bib0060) 2002; 68 Neske, Blessing, Tollmann, Schubert, Rethwilm, Kreth (bib0085) 2007; 45 Gregersen (bib0045) 2008; 26 Schild, Oxford, de Jong, Webster (bib0005) 1983; 303 Bosis, Esposito, Niesters, Crovari, Osterhaus, Principi (bib0130) 2005; 75 Minor, Engelhardt, Wood, Robertson, Trusheim, Blayer (bib0035) 2009; 27 Oberste, Maher, Flemister, Marchetti, Kilpatrick, Pallansch (bib0065) 2000; 38 Xiang, Gonzalez, Xie, Xiao, Chen, Li (bib0075) 2008; 14 Hu, Colella, Tam, Rappaport, Cheng (bib0055) 2003; 41 Katz (10.1016/j.vaccine.2011.11.063_bib0025) 1990; 64 Genzel (10.1016/j.vaccine.2011.11.063_bib0030) 2009; 8 Oberste (10.1016/j.vaccine.2011.11.063_bib0065) 2000; 38 Oxford (10.1016/j.vaccine.2011.11.063_bib0015) 1987; 65 Gregersen (10.1016/j.vaccine.2011.11.063_bib0040) 2008; 26 Matthews (10.1016/j.vaccine.2011.11.063_bib0100) 2006; 36 Robertson (10.1016/j.vaccine.2011.11.063_bib0010) 1993; 3 Manning (10.1016/j.vaccine.2011.11.063_bib0115) 2006; 194 Minor (10.1016/j.vaccine.2011.11.063_bib0110) 2010; 50 Gregersen (10.1016/j.vaccine.2011.11.063_bib0045) 2008; 26 De Vos (10.1016/j.vaccine.2011.11.063_bib0125) 2009; 28 Schild (10.1016/j.vaccine.2011.11.063_bib0005) 1983; 303 Dare (10.1016/j.vaccine.2011.11.063_bib0080) 2007; 196 Bosis (10.1016/j.vaccine.2011.11.063_bib0130) 2005; 75 Gerdil (10.1016/j.vaccine.2011.11.063_bib0095) 2003; 21 Xiang (10.1016/j.vaccine.2011.11.063_bib0075) 2008; 14 Stempel (10.1016/j.vaccine.2011.11.063_bib0120) 2009; 98 Katz (10.1016/j.vaccine.2011.11.063_bib0020) 1989; 160 Frank (10.1016/j.vaccine.2011.11.063_bib0140) 1979; 10 Ward (10.1016/j.vaccine.2011.11.063_bib0050) 2004; 29 Hu (10.1016/j.vaccine.2011.11.063_bib0055) 2003; 41 Eggers (10.1016/j.vaccine.2011.11.063_bib0135) 2011 Dare (10.1016/j.vaccine.2011.11.063_bib0090) 2007; 45 Neske (10.1016/j.vaccine.2011.11.063_bib0085) 2007; 45 Minor (10.1016/j.vaccine.2011.11.063_bib0035) 2009; 27 Venter (10.1016/j.vaccine.2011.11.063_bib0060) 2002; 68 Ulmer (10.1016/j.vaccine.2011.11.063_bib0105) 2006; 24 Mori (10.1016/j.vaccine.2011.11.063_bib0070) 1994; 44 |
References_xml | – year: 2011 ident: bib0135 article-title: Comparison of the novel ResPlex III assay and existing techniques for the detection and subtyping of influenza virus during the influenza season 2006–2007 publication-title: Eur J Microbiol Infect Dis – volume: 27 start-page: 2907 year: 2009 end-page: 2913 ident: bib0035 article-title: Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK publication-title: Vaccine – volume: 26 start-page: 3297 year: 2008 end-page: 3304 ident: bib0040 article-title: A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines publication-title: Vaccine – volume: 29 start-page: 179 year: 2004 end-page: 188 ident: bib0050 article-title: Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement publication-title: J Clin Virol – volume: 64 start-page: 1808 year: 1990 end-page: 1811 ident: bib0025 article-title: Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus publication-title: J Virol – volume: 41 start-page: 149 year: 2003 end-page: 154 ident: bib0055 article-title: Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR publication-title: J Clin Microbiol – volume: 45 start-page: 548 year: 2007 end-page: 552 ident: bib0090 article-title: Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis publication-title: J Clin Microbiol – volume: 24 start-page: 1377 year: 2006 end-page: 1383 ident: bib0105 article-title: Vaccine manufacturing: challenges and solutions publication-title: Nat Biotechnol – volume: 98 start-page: 123 year: 2009 end-page: 126 ident: bib0120 article-title: Multiple viral respiratory pathogens in children with bronchiolitis publication-title: Acta Paediatr – volume: 28 start-page: 1305 year: 2009 end-page: 1310 ident: bib0125 article-title: Simultaneous detection of human bocavirus and adenovirus by multiplex real-time PCR in a Belgian paediatric population publication-title: Eur J Clin Microbiol Infect Dis – volume: 36 start-page: 17 year: 2006 end-page: 24 ident: bib0100 article-title: Egg-based production of influenza vaccine: 30 years of commercial experience publication-title: The Bridge – volume: 160 start-page: 191 year: 1989 end-page: 198 ident: bib0020 article-title: Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs publication-title: J Infect Dis – volume: 8 start-page: 1681 year: 2009 end-page: 1692 ident: bib0030 article-title: Continuous cell lines as a production system for influenza vaccines publication-title: Expert Rev Vaccines – volume: 50 start-page: 560 year: 2010 end-page: 565 ident: bib0110 article-title: Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production publication-title: Clin Infect Dis – volume: 14 start-page: 1665 year: 2008 end-page: 1667 ident: bib0075 article-title: Human rhinovirus group C infection in children with lower respiratory tract infection publication-title: Emerg Infect Dis – volume: 44 start-page: 323 year: 1994 end-page: 329 ident: bib0070 article-title: Polymerase chain reaction and sequencing for typing rhinovirus RNA publication-title: J Med Virol – volume: 26 start-page: 3332 year: 2008 end-page: 3340 ident: bib0045 article-title: A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine publication-title: Vaccine – volume: 10 start-page: 32 year: 1979 end-page: 36 ident: bib0140 article-title: Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses publication-title: J Clin Microbiol – volume: 303 start-page: 706 year: 1983 end-page: 709 ident: bib0005 article-title: Evidence for host-cell selection of influenza virus antigenic variants publication-title: Nature – volume: 68 start-page: 452 year: 2002 end-page: 461 ident: bib0060 article-title: Molecular epidemiological analysis of community circulating respiratory syncytial virus in rural South Africa: comparison of viruses and genotypes responsible for different disease manifestations publication-title: J Med Virol – volume: 194 start-page: 1283 year: 2006 end-page: 1290 ident: bib0115 article-title: Epidemiological profile and clinical associations of human bocavirus and other human parvovirus publication-title: J Infect Dis – volume: 75 start-page: 101 year: 2005 end-page: 104 ident: bib0130 article-title: Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses publication-title: J Med Virol – volume: 38 start-page: 1170 year: 2000 end-page: 1174 ident: bib0065 article-title: Comparison of classic and molecular approaches for the identification of untypeable enteroviruses publication-title: J Clin Microbiol – volume: 21 start-page: 1776 year: 2003 end-page: 1779 ident: bib0095 article-title: The annual production cycle for influenza vaccine publication-title: Vaccine – volume: 65 start-page: 181 year: 1987 end-page: 187 ident: bib0015 article-title: Serological studies with influenza A (H1N1) viruses cultivated in eggs or in canine kidney cell line (MDCK) publication-title: Bull WHO – volume: 45 start-page: 2116 year: 2007 end-page: 2122 ident: bib0085 article-title: Real-time PCR for diagnosis of human bocavirus infections and phylogenetic analysis publication-title: J Clin Microbiol – volume: 3 start-page: 97 year: 1993 end-page: 106 ident: bib0010 article-title: Clinical influenza virus and the embryonated hen's egg publication-title: Med Virol – volume: 196 start-page: 1321 year: 2007 end-page: 1328 ident: bib0080 article-title: Human coronavirus infections in rural Thailand: a comprehensive study using real-time reverse-transcription polymerase chain reaction assays publication-title: J Infect Dis – volume: 65 start-page: 181 year: 1987 ident: 10.1016/j.vaccine.2011.11.063_bib0015 article-title: Serological studies with influenza A (H1N1) viruses cultivated in eggs or in canine kidney cell line (MDCK) publication-title: Bull WHO – volume: 64 start-page: 1808 year: 1990 ident: 10.1016/j.vaccine.2011.11.063_bib0025 article-title: Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus publication-title: J Virol doi: 10.1128/JVI.64.4.1808-1811.1990 – volume: 27 start-page: 2907 year: 2009 ident: 10.1016/j.vaccine.2011.11.063_bib0035 article-title: Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK publication-title: Vaccine doi: 10.1016/j.vaccine.2009.02.064 – volume: 36 start-page: 17 year: 2006 ident: 10.1016/j.vaccine.2011.11.063_bib0100 article-title: Egg-based production of influenza vaccine: 30 years of commercial experience publication-title: The Bridge – volume: 24 start-page: 1377 year: 2006 ident: 10.1016/j.vaccine.2011.11.063_bib0105 article-title: Vaccine manufacturing: challenges and solutions publication-title: Nat Biotechnol doi: 10.1038/nbt1261 – volume: 28 start-page: 1305 year: 2009 ident: 10.1016/j.vaccine.2011.11.063_bib0125 article-title: Simultaneous detection of human bocavirus and adenovirus by multiplex real-time PCR in a Belgian paediatric population publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-009-0780-y – volume: 26 start-page: 3297 year: 2008 ident: 10.1016/j.vaccine.2011.11.063_bib0040 article-title: A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines publication-title: Vaccine doi: 10.1016/j.vaccine.2008.03.076 – volume: 8 start-page: 1681 year: 2009 ident: 10.1016/j.vaccine.2011.11.063_bib0030 article-title: Continuous cell lines as a production system for influenza vaccines publication-title: Expert Rev Vaccines doi: 10.1586/erv.09.128 – volume: 45 start-page: 548 issue: February (2) year: 2007 ident: 10.1016/j.vaccine.2011.11.063_bib0090 article-title: Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis publication-title: J Clin Microbiol doi: 10.1128/JCM.01621-06 – volume: 21 start-page: 1776 year: 2003 ident: 10.1016/j.vaccine.2011.11.063_bib0095 article-title: The annual production cycle for influenza vaccine publication-title: Vaccine doi: 10.1016/S0264-410X(03)00071-9 – volume: 14 start-page: 1665 year: 2008 ident: 10.1016/j.vaccine.2011.11.063_bib0075 article-title: Human rhinovirus group C infection in children with lower respiratory tract infection publication-title: Emerg Infect Dis doi: 10.3201/eid1410.080545 – volume: 303 start-page: 706 year: 1983 ident: 10.1016/j.vaccine.2011.11.063_bib0005 article-title: Evidence for host-cell selection of influenza virus antigenic variants publication-title: Nature doi: 10.1038/303706a0 – volume: 44 start-page: 323 year: 1994 ident: 10.1016/j.vaccine.2011.11.063_bib0070 article-title: Polymerase chain reaction and sequencing for typing rhinovirus RNA publication-title: J Med Virol doi: 10.1002/jmv.1890440403 – volume: 75 start-page: 101 year: 2005 ident: 10.1016/j.vaccine.2011.11.063_bib0130 article-title: Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses publication-title: J Med Virol doi: 10.1002/jmv.20243 – volume: 194 start-page: 1283 year: 2006 ident: 10.1016/j.vaccine.2011.11.063_bib0115 article-title: Epidemiological profile and clinical associations of human bocavirus and other human parvovirus publication-title: J Infect Dis doi: 10.1086/508219 – volume: 38 start-page: 1170 year: 2000 ident: 10.1016/j.vaccine.2011.11.063_bib0065 article-title: Comparison of classic and molecular approaches for the identification of untypeable enteroviruses publication-title: J Clin Microbiol doi: 10.1128/JCM.38.3.1170-1174.2000 – year: 2011 ident: 10.1016/j.vaccine.2011.11.063_bib0135 article-title: Comparison of the novel ResPlex III assay and existing techniques for the detection and subtyping of influenza virus during the influenza season 2006–2007 publication-title: Eur J Microbiol Infect Dis – volume: 98 start-page: 123 year: 2009 ident: 10.1016/j.vaccine.2011.11.063_bib0120 article-title: Multiple viral respiratory pathogens in children with bronchiolitis publication-title: Acta Paediatr doi: 10.1111/j.1651-2227.2008.01023.x – volume: 3 start-page: 97 year: 1993 ident: 10.1016/j.vaccine.2011.11.063_bib0010 article-title: Clinical influenza virus and the embryonated hen's egg publication-title: Med Virol doi: 10.1002/rmv.1980030206 – volume: 160 start-page: 191 year: 1989 ident: 10.1016/j.vaccine.2011.11.063_bib0020 article-title: Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs publication-title: J Infect Dis doi: 10.1093/infdis/160.2.191 – volume: 41 start-page: 149 year: 2003 ident: 10.1016/j.vaccine.2011.11.063_bib0055 article-title: Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR publication-title: J Clin Microbiol doi: 10.1128/JCM.41.1.149-154.2003 – volume: 29 start-page: 179 year: 2004 ident: 10.1016/j.vaccine.2011.11.063_bib0050 article-title: Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement publication-title: J Clin Virol doi: 10.1016/S1386-6532(03)00122-7 – volume: 68 start-page: 452 year: 2002 ident: 10.1016/j.vaccine.2011.11.063_bib0060 article-title: Molecular epidemiological analysis of community circulating respiratory syncytial virus in rural South Africa: comparison of viruses and genotypes responsible for different disease manifestations publication-title: J Med Virol doi: 10.1002/jmv.10225 – volume: 196 start-page: 1321 issue: November (9) year: 2007 ident: 10.1016/j.vaccine.2011.11.063_bib0080 article-title: Human coronavirus infections in rural Thailand: a comprehensive study using real-time reverse-transcription polymerase chain reaction assays publication-title: J Infect Dis doi: 10.1086/521308 – volume: 45 start-page: 2116 issue: July (7) year: 2007 ident: 10.1016/j.vaccine.2011.11.063_bib0085 article-title: Real-time PCR for diagnosis of human bocavirus infections and phylogenetic analysis publication-title: J Clin Microbiol doi: 10.1128/JCM.00027-07 – volume: 10 start-page: 32 year: 1979 ident: 10.1016/j.vaccine.2011.11.063_bib0140 article-title: Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses publication-title: J Clin Microbiol doi: 10.1128/JCM.10.1.32-36.1979 – volume: 50 start-page: 560 year: 2010 ident: 10.1016/j.vaccine.2011.11.063_bib0110 article-title: Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production publication-title: Clin Infect Dis doi: 10.1086/650171 – volume: 26 start-page: 3332 year: 2008 ident: 10.1016/j.vaccine.2011.11.063_bib0045 article-title: A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine publication-title: Vaccine doi: 10.1016/j.vaccine.2008.03.075 |
SSID | ssj0005319 |
Score | 2.1152802 |
Snippet | ► Multiplex PCR screening of clinical specimens from acute respiratory tract infections. ► Viruses found were influenza, entero/rhino, corona, adeno, boca, PI,... Highlights► Multiplex PCR screening of clinical specimens from acute respiratory tract infections. ► Viruses found were influenza, entero/rhino, corona, adeno,... This paper summarizes results obtained by multiplex PCR screening of human clinical samples for respiratory viruses and corresponding data obtained after... Highlights * Multiplex PCR screening of clinical specimens from acute respiratory tract infections. * Viruses found were influenza, entero/rhino, corona,... |
SourceID | pubmedcentral proquest pubmed crossref fao elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 517 |
SubjectTerms | Adenovirus Adenoviruses Adventitious viruses Allergy and Immunology Animals Binding sites Blood Bocaparvovirus Bocavirus Cell culture Cell Line Coinfection - virology Coronavirinae Coronavirus Dogs Eggs Enterovirus Germany Humans Influenza Influenza vaccine Influenza virus inoculum MDCK cells Multiplex Polymerase Chain Reaction Mutation Orthocoronavirinae Orthomyxoviridae Parainfluenza virus polymerase chain reaction Respiratory syncytial virus Respiratory tract Respiratory Tract Infections - diagnosis Respiratory Tract Infections - virology Rhinovirus screening Vaccines Virology - methods Virus Cultivation - methods Virus Diseases - diagnosis Virus Diseases - virology Virus isolation Viruses Viruses - genetics Viruses - growth & development Viruses - isolation & purification |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYEIgXBAW2wEBGQntatiRObOcJoUE1QEWVtqK-WbbjjE4oGU07afz13OWToX3w2vjy0Tuff-c7_46Qd3EuuRHc-FkuMM3IAl-aPPG1dcaEsQ4Th4Hi5Bs_msVf5sm83XCr2rLKzifWjjorLe6RHwCSF7CWcxa8P__lY9cozK62LTQ2yH2kLsOSLjEXQ4kHqxt7QJgRw2sE8-EEz8HZ_oW2mLpuWDyRyJOzm9amjVyX1yHQfwsp_1qZxk_I4xZS0g-NDTwl91wxIg-aJpOXI_Jw0qbPR2R32hBVX-7Rk-HcVbVHd-l0oLAGmdF3rJKpj-rSTvwZOf0MhlprkpY5XTTtTX5rerFYritXwS908vHwK2Uwnfl0TDEpUFFdZNRicwq0LxTE6niNFThYcU2XQ66_u9FzMht_Ojk88ttGDb6FcGPlO55KIVzqhNbM2MjFApEcICOnozi3MnGJyR23LDKRtHGWM2MYDJOZTrPEsRdksygLt01omOnM6UC6NGGxTCMdBwZApsk4QCXujEfiTkXKtizm2Ezjp-rK1c5Uq1mFmoUIR4FmPbLfi503NB53CfBO_6o7owpeVcFCc5eguE7QVa1vqFSoqkgF6jiosWgwD5E0DeI6j8hesoU_Daz5n4dug4kqfQoLg5odR7iNBbEvPCDyyE5nt2p4hX4yeeRtfxkcCxqGLly5hjEAYxIAK3gLesOYFHScCin5bUMkUgax0CNbzWTpFRAhu2Aawf3FlWnUD0Dq86tXisWPmgJdgFORIXt5-8e9Io_gr8DSIz8Md8jmarl2rwFDrsyb2lH8AZ2DcCY priority: 102 providerName: ProQuest |
Title | Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X11018597 https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X11018597 https://dx.doi.org/10.1016/j.vaccine.2011.11.063 https://www.ncbi.nlm.nih.gov/pubmed/22119922 https://www.proquest.com/docview/1497392630 https://www.proquest.com/docview/1678529942 https://www.proquest.com/docview/912797886 https://www.proquest.com/docview/918053731 https://pubmed.ncbi.nlm.nih.gov/PMC7130813 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGEIgXBAW2wEBGQnta2iRObOdxlFUdU6uKrahvlp04oxNKp6adNB7427nLR7vCxhAvaZvcOVHufPdzfR-EfAgzyY3gxk0zgduMzHOlySJXJ9YYP9R-ZHGhOBjy_jj8PIkmW6Tb5MJgWGVt-yubXlrr-kynfpudy-m0c-qVvtyb-Fh0CnAxZrCHArW8_fNGmAcrm3sgsYvU6yyezkX7Sie4fV1V8sRinpzd5Z8eZHp2Gwr9PZjyhnfqPSNPa1hJD6snf062bN4ij6pGk9ct8nhQb6G3yP6oKlZ9fUDP1rlXxQHdp6N1GWvgaX3FSJkyXZc27C_I-TEoaylNOsvotGpx8kPTq-l8WdgCztDBp-4JZTCl-ahHcWOgoDpPaYINKlDHkBEj5DVG4WDUNZ2v9_ubgV6Sce_orNt362YNbgJLjoVreSyFsLEVWjOTBDYUiOYAHVkdhFkiIxuZzPKEBSaQSZhmzBgGZDLVcRpZ9ops57Pc7hLqpzq12pM2jlgo40CHngGgaVIOcIlb45CwEZFK6krm2FDju2pC1i5ULVmFkoVVjgLJOqS9YrusSnncx8Ab-asmTxUsqwJncx-juI3RFrV9KJSvikB56g8ddohccW5Mg3-56S6oqNLn4BzU-DTAv7Jg_Qs3CByy1-itWj9CGAsAx5x5Dnm_ugzGBRVD53a2BBqAMhEAFhyC3kETg4xjISX_G4nEskHMd8hONVlWAgiwwmAcwPhiYxqtCLD8-eaVfPqtLIMuwLBIn73-_1f2hjyBXxia5Pr-HtlezJf2LWDMhXlXGhE4iomAo-zC94eHxyf9IXx-PBqOvvwCVLN_JA |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF61qXhcEIRHDQUWCXqqW9trr-0DQtA2SkgTRbSpclt27XVJhZISJ0XhR_EbmfGToj649BrvrGPP7Mw33tlvCHnrJgFXPldmnPi4zcgsM1CJZ8pIK2W70vY0Joq9Pm8P3c8jb7RCfpdnYbCssvSJmaOOpxF-I98BJO9DLOfM-nD2w8SuUbi7WrbQyM2iq5c_IWVL33f2QL_vHKe1f7TbNouuAmYE2Hhuag5ptq9D7UvJVORo10fYAWFcS8dNosDTnko0j5ijnCBy44QpxWBYEMsw9jSDeVfJmssglWmQtU_7_cGXuqiEZa1EILFx4cGtUX1maOd0-1xGuFme84YidShnV0XD1UROL8O8_5Zu_hULWw_JgwLE0o-51T0iK3rSJHfytpbLJrnbKzbsm2RzkFNjL7foUX3SK92im3RQk2aDTPMY63Kyw8G0FH9MTjqwNDLbodOEjvOGKr8kPR_PFqlO4Rfa29vtUgYOhA9aFLchUionMY2wHQZaNApiPb7Emh-s8aazurqgnOgJGd6KEp-SxmQ60euE2rGMtbQCHXrMDUJHupYCWKtiDuCMa2UQt1SRiAredGzf8V2UBXKnotCsQM1CTiVAswbZrsTOcuKQmwR4qX9RnooFPy4gtN0k6F8mqNPCG6XCFqkjLHFoZejXGtlI0waZpEGCSrIAXDmQ-p-broOJCnkCoUgMDx38cAbZNtzAMchGabei_gvV8jXIm-oyuDI0DDnR0wWMAeDkATzCKegVY0LQcegHAb9uSIAkRcw2yLN8sVQKcJDPMHRgfv_CMqoGINn6xSuT8beMdN0HNxbY7Pn1D_ea3Gsf9Q7EQafffUHuw2vBwifTtjdIYz5b6JeAYOfqVeE2KPl6257qDx-0r98 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe2ISZeEJSPBQYYCfa0rImdxMkDQmilWimdKm1FfTN24oxOqB1NO1T-NP467vLJ0D542Wvjc5rc-e538fl3hLzx0jDQItB2kgrcZuSOHerUt1VstHY95foGE8XBYXAw8j6N_fEa-V2dhcGyyson5o46mcX4jbwNSF5ALA-4007Lsohhp_v-7IeNHaRwp7Vqp1GYSN-sfkL6lr3rdUDXbxnrfjzeP7DLDgN2DDh5YZsAUm5hIiOU4jpmxhMIQSCkG8W8NA594-vUBDFnmoWxl6Rcaw7DwkRFiW84zLtO7gjuu7jGxFg05SU8byoCKY4Hr8AZN6eH2qd75yrGbfOCQRRJRAN-VVxcT9XsMvT7bxHnX1Gx-4DcL-Es_VDY30OyZqYtcrdocLlqkc1BuXXfIjvDgiR7tUuPmzNf2S7docOGPhtkWl-wQic_Jkwr8UfkpAeLJLciOkvppGit8kvR88l8mZkMfqGDzn6fcnAlwbBLcUMio2qa0BgbY6BtoyBW5ius_sFqbzpv6gyqiR6T0a2o8AnZmM6mZotQN1GJUU5oIp97YcSU52gAuDoJAKYFRlvEq1Qk45JBHRt5fJdVqdypLDUrUbOQXUnQrEX2arGzgkLkJoGg0r-szseCR5cQ5G4SFJcJmqz0S5l0ZcakI4-cHAc7YxcJ2yCntEhYS5bQq4BU_3PTLTBRqU4gKMnREcNPaJB3ww2YRbYru5XNX6gXskVe15fBqaFhqKmZLWEMQCgfgBJOQa8YE4GOIxGGwXVDQqQr4q5FnhaLpVYAQ2bDiMH84sIyqgcg7frFK9PJt5x-XYBDC13-7PqHe0U2wT_Jz73D_nNyD94KKz7cbZONxXxpXgCUXeiXuc-g5OttO6k_MVCyrg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Isolation+of+influenza+viruses+in+MDCK+33016PF+cells+and+clearance+of+contaminating+respiratory+viruses&rft.jtitle=Vaccine&rft.au=Roth%2C+Bernhard&rft.au=Mohr%2C+Hannah&rft.au=Enders%2C+Martin&rft.au=Garten%2C+Wolfgang&rft.date=2012-01-11&rft.pub=Elsevier+Ltd&rft.issn=0264-410X&rft.eissn=1873-2518&rft.volume=30&rft.issue=3&rft.spage=517&rft.epage=522&rft_id=info:doi/10.1016%2Fj.vaccine.2011.11.063&rft_id=info%3Apmid%2F22119922&rft.externalDocID=PMC7130813 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X11X00531%2Fcov150h.gif |